Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

THE TRUTH ABOUT: Epizyme - The Untold Story

Pharma Exec To Plead Guilty In Insider Trading Case: Report

Dishant Gupta allegedly used his wife's brokerage account to make more than $262,000 in illegal profits.

International Business Times

Benzinga's Top Ratings Upgrades, Downgrades For June 28, 2022

Benzinga's Top Ratings Upgrades, Downgrades For June 28, 2022

Benzinga's Top Ratings Upgrades, Downgrades For June 27, 2022

Benzinga's Top Ratings Upgrades, Downgrades For June 27, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Why Epizyme Shares Are Soaring Today

Epizyme Inc (NASDAQ: EPZM) shares are trading higher Monday after the company announced it entered into a definitive agreement to be acquired by Ipsen.

Epizyme's Return On Capital Employed Insights

Epizyme (NASDAQ:EPZM) brought in sales totaling $8.70 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 9.58%, resulting in a loss of $55.51 million.

Epizyme: Q1 Earnings Insights

Epizyme (NASDAQ:EPZM) reported its Q1 earnings results on Tuesday, May 10, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

Epizyme Earnings Preview

Epizyme (NASDAQ:EPZM) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Epizyme will report an earnings per share (EPS) of $-0.35.

inkl

Read news from The Economist, FT, and more,
with one subscription

Epizyme's Return On Capital Employed Insights

Epizyme's Return On Capital Employed Insights

According to Benzinga Pro data, during Q4, Epizyme (NASDAQ:EPZM) posted sales of $11.58 million. Earnings were up 23.06%, but Epizyme still reported an overall loss of $50.65 million.

Recap: Epizyme Q4 Earnings

Recap: Epizyme Q4 Earnings

Epizyme (NASDAQ:EPZM) reported its Q4 earnings results on Tuesday, March 1, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

12 Health Care Stocks Moving In Tuesday's After-Market Session

12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers Epizyme (NASDAQ:EPZM) shares increased by 7.3% to $1.32 during Tuesday's after-market session. Epizyme's trading volume hit 240.6K shares by close, accounting for 10.7% of its average volume over the last 100 days. The company's market cap stands at $140.0 million.

Epizyme Raises $85M Via Equity Issued At 21% Discount

Epizyme Raises $85M Via Equity Issued At 21% Discount

Epizyme Inc (NASDAQ: EPZM) has priced its underwritten public offering of 56.7 million shares at

1

Organisations

Bed, Bath & Beyond

Chipotle Mexican Grill

Robinhood Markets

Coinbase Global

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Places

396,108 stories

inkl

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play